logo

Finasteride and the risk of sexual dysfunction: results from a large UK patient database

A possible side effect of 5-α reductase inhibitors is sexual dysfunction and some men, particularly those being treated for alopecia, report that sexual dysfunction continues after the withdrawal of treatment.

However, there is little robust evidence to quantify the risk of sexual dysfunction associated with finasteride use for alopecia or the underlying pathophysiology of such an effect.

testosterone prescription on the riseA recent study assessing the risk of erectile dysfunction and non-erectile dysfunction sexual dysfunction in men who used 5-α reductase inhibitors to treat benign prostatic hyperplasia or alopecia has been published in the British Medical Journal. The results suggest that 5-α reductase inhibitors do not significantly increase the risk of incident erectile dysfunction, regardless of indication for use, in men free of sexual dysfunction and major risk factors at baseline.

Read more in our journal article reviews.

This entry was posted in Erectile dysfunction, Men's health, Prostate disease, Research and Evaluation, Sexual health. Bookmark the permalink.
Website by Essendon Creative